Articles

Results 1 to 5 of 40


Delaware Chancery Court Strikes 5% Poison Pill With "Extreme" Features

USA - March 3 2021 The Delaware Chancery Court held that a Board of Directors breached its fiduciary duties in adopting a shareholder rights plan, or "poison pill," with…

Randi C. Lesnick, James P. Dougherty, Jennifer C. Lewis, Robert A. Profusek, Lizanne Thomas

ISS Issues Policy Guidance in Response to COVID-19

USA - April 11 2020 In Short The Background: The novel coronavirus (COVID-19) pandemic has presented unprecedented uncertainties and challenges to public companies for…

Randi C. Lesnick, James P. Dougherty, Robert A. Profusek, Lizanne Thomas

To Adopt or Not to Adopt: Poison Pills in the Wake of COVID-19

USA - March 24 2020 Equity prices have collapsed in the past month, making many companies vulnerable to opportunistic and abusive takeovers and…

Randi C. Lesnick, James P. Dougherty, Robert A. Profusek, Lizanne Thomas

ISS's 2020 "EVA" Assessment: How Will Your CEO Perform?

USA - March 7 2020 Beginning with this proxy season, ISS will use metrics based on "EVA"—economic value added—as part of its pay-for-performance analyses. ISS claims…

Randi C. Lesnick, James P. Dougherty, Jennifer C. Lewis, Robert A. Profusek, Lizanne Thomas

Share Buybacks Under Fire

USA - April 16 2019 Corporate share buybacks skyrocketed in today's low interest rate environment and the trend is likely to continue…

Randi C. Lesnick, James P. Dougherty, Robert A. Profusek, Lizanne Thomas